Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.370
-0.410 (-8.58%)
At close: Jun 5, 2026, 4:00 PM EDT
4.340
-0.030 (-0.69%)
After-hours: Jun 5, 2026, 7:26 PM EDT

Sampath Bank Statistics

Total Valuation

LXEO has a market cap or net worth of $343.14 million. The enterprise value is $157.46 million.

Market Cap343.14M
Enterprise Value 157.46M

Important Dates

The last earnings date was Monday, May 11, 2026, before market open.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

LXEO has 78.52 million shares outstanding. The number of shares has increased by 98.55% in one year.

Current Share Class 78.52M
Shares Outstanding 78.52M
Shares Change (YoY) +98.55%
Shares Change (QoQ) +6.32%
Owned by Insiders (%) 0.26%
Owned by Institutions (%) 76.22%
Float 47.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.40
P/TBV Ratio 1.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.16, with a Debt / Equity ratio of 0.03.

Current Ratio 14.16
Quick Ratio 13.61
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,164.11

Financial Efficiency

Return on equity (ROE) is -54.75% and return on invested capital (ROIC) is -36.34%.

Return on Equity (ROE) -54.75%
Return on Assets (ROA) -32.50%
Return on Invested Capital (ROIC) -36.34%
Return on Capital Employed (ROCE) -41.41%
Weighted Average Cost of Capital (WACC) 11.66%
Revenue Per Employee n/a
Profits Per Employee -$1.48M
Employee Count59
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +40.97% in the last 52 weeks. The beta is 1.39, so LXEO's price volatility has been higher than the market average.

Beta (5Y) 1.39
52-Week Price Change +40.97%
50-Day Moving Average 5.67
200-Day Moving Average 7.16
Relative Strength Index (RSI) 34.88
Average Volume (20 Days) 793,538

Short Selling Information

The latest short interest is 13.21 million, so 16.83% of the outstanding shares have been sold short.

Short Interest 13.21M
Short Previous Month 13.07M
Short % of Shares Out 16.83%
Short % of Float 27.81%
Short Ratio (days to cover) 18.84

Income Statement

Revenue n/a
Gross Profit -62.33M
Operating Income -97.79M
Pretax Income -87.50M
Net Income -87.50M
EBITDA -97.18M
EBIT -97.79M
Earnings Per Share (EPS) -$1.33
Full Income Statement

Balance Sheet

The company has $193.04 million in cash and $7.37 million in debt, with a net cash position of $185.68 million or $2.36 per share.

Cash & Cash Equivalents 193.04M
Total Debt 7.37M
Net Cash 185.68M
Net Cash Per Share $2.36
Equity (Book Value) 231.50M
Book Value Per Share 3.12
Working Capital 186.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$97.99 million and capital expenditures -$432,000, giving a free cash flow of -$98.42 million.

Operating Cash Flow -97.99M
Capital Expenditures -432,000
Depreciation & Amortization 601,000
Net Borrowing -495,000
Free Cash Flow -98.42M
FCF Per Share -$1.25
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -98.55%
Shareholder Yield -98.55%
Earnings Yield -25.50%
FCF Yield -28.68%

Analyst Forecast

The average price target for LXEO is $20.60, which is 371.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.60
Price Target Difference 371.40%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1